nirs utilizationduringfirsthoursand daysoflife -...
TRANSCRIPT
1
Medizinische Universität Graz, Universitätsplatz 3, A-8010 Graz, www.medunigraz.at
NIRS utilization during first hours anddays of life
Berndt Urlesberger, MDProfessor of Neonatology
Division of Neonatology, Department of PediatricsMedical University Graz, Austria
Email: [email protected]
B. Urlesberger, Div. Neonatology, Medical University Graz
Definitions
8 Pulse-oximetry– SpO2 – Arterial Oxygen saturation
8 Nearinfrared Spectroscopy (NIRS)– rStO2– Regional tissue oxygen saturation (mixed oxygen saturation)– Venous:arterial = 75:25
B. Urlesberger, Div. Neonatology, Medical University Graz
Oxygen saturation parameters
8 Peripheral oxygen saturation– SpO2 (peripheral arterial oxygen saturation)– mrStO2 (regional tissue oxygen saturation - muscle)
8 Cerebral oxygen saturation– crStO2 (cerebral regional tissue oxygen saturation) – TOI (cerebral regional tissue oxygen saturation)
2
B. Urlesberger, Div. Neonatology, Medical University Graz
Are there differences between peripheral and cerebral oxygenation ?
B. Urlesberger, Div. Neonatology, Medical University Graz
B. Urlesberger, Div. Neonatology, Medical University Graz
Immediate Transition
Cerebral oxygenation may show a different behavior compared to peripheral arterial oxygenation
during immediate transition
J Pediatr 2011
3
B. Urlesberger, Div. Neonatology, Medical University Graz
Cerebral oxygenation may show a different behavior compared to peripheral arterial oxygenation
during respiratory support in NICUJ Pediatr 2015
B. Urlesberger, Div. Neonatology, Medical University Graz
Why are there differences ?
B. Urlesberger, Div. Neonatology, Medical University Graz
4
B. Urlesberger, Div. Neonatology, Medical University Graz
B. Urlesberger, Div. Neonatology, Medical University Graz
Lower cerebral rStO2 levels in infants with respiratory support might not only be due to lower oxygen delivery, but there might be associations with changes in cerebral perfusion!
B. Urlesberger, Div. Neonatology, Medical University Graz
Immediate Transition
Subjects 109Gender f : m 55 : 54
GA(wks) 38.8 (1.0)BW(g) 3242 (481)
There is a significant decrease in CBV during neonatal transition, theamount of decrease is 25%-50% of total CBV.
5
B. Urlesberger, Div. Neonatology, Medical University Graz
We observed a less pronounced decrease of CBV in infants in needof RS, compared to infants with normal transition .
Changes in CBV of Term and Preterm Infants with and without Respiratory Support after Birth Unpublished data,
Manuscript submitted
B. Urlesberger, Div. Neonatology, Medical University Graz
How about normal values or target ranges for cerebral oxygen saturation ?
B. Urlesberger, Div. Neonatology, Medical University Graz
6
B. Urlesberger, Div. Neonatology, Medical University Graz
Normal values for neonates during immediate transition, and preterm infants during first 72h
are established
B. Urlesberger, Div. Neonatology, Medical University Graz
Are we able to aim for these target ranges ? And does it matter ?
B. Urlesberger, Div. Neonatology, Medical University Graz
C erebralO xygen S aturation toG uide O xygenD elivery
7
B. Urlesberger, Div. Neonatology, Medical University Graz
Dawson et al, Pediatrics 2010
B. Urlesberger, Div. Neonatology, Medical University Graz
Pichler et al, J Pediatr 2013
B. Urlesberger, Div. Neonatology, Medical University Graz
Was it possible to keep crStO2 >10th perc ?Yes !
Pichler et al, J Pediatr 2016
NIRS visible
NIRS not visible
rStO2, 10th percentile
8
B. Urlesberger, Div. Neonatology, Medical University Graz
Does it matter ?
openNIRS visible
closedNIRS not visible
Pichler et al, J Pediatr 2016
B. Urlesberger, Div. Neonatology, Medical University Graz
Spearmans ρ = -0.78, p = 0.02
B. Urlesberger, Div. Neonatology, Medical University Graz
Infants without IVH
10th Percentile
Infants developed IVH later on
9
B. Urlesberger, Div. Neonatology, Medical University Graz
SafeBoosC: Phase II trial to test the hypothesis that the burden of hypoxia and hyperoxia could be reduced by the combination of cerebral NIRS monitoring and a dedicated treatment guideline – and to demonstrate the feasibility of such an approach.
85%
55%
SafeguardingtheBrainofoursmallestChildren
B. Urlesberger, Div. Neonatology, Medical University Graz
Treatment Protocol
rStO2 <55%
CRT
Lactate Onvasopressors?
[Hb]low
BloodPressure
Cardiovascularstatus
Considerreducingvasopressor
Clinicalassessment
Considervolumeexpansion,vasopressor/inotropes,decreaseMAP
ConsiderRBCtransfusion
Considertreatment
Urineoutput
Echocardiography
rStO2 >85%
PDA
LowCO/SVCflow Considervolumeexpansion,inotropes,decreaseMAP
Oxygentransport
RespiratorystatusSaO2 low
PCO2 low
ConsiderincreaseFiO2
ConsiderdecreaseMV
ConsiderdecreaseFiO2
ConsiderincreaseMV
Respiratorystatus
SaO2 high
PCO2 high
Bloodglucoselevel
LowConsiderincreaseglucoseintake
SafeBoosC
B. Urlesberger, Div. Neonatology, Medical University Graz
Treatment Protocol
rStO2 <55%
CRT
Lactate Onvasopressors?
[Hb]low
BloodPressure
Cardiovascularstatus
Considerreducingvasopressor
Clinicalassessment
Considervolumeexpansion,vasopressor/inotropes,decreaseMAP
ConsiderRBCtransfusion
Considertreatment
Urineoutput
Echocardiography
rStO2 >85%
PDA
LowCO/SVCflow Considervolumeexpansion,inotropes,decreaseMAP
Oxygentransport
RespiratorystatusSaO2 low
PCO2 low
ConsiderincreaseFiO2
ConsiderdecreaseMV
ConsiderdecreaseFiO2
ConsiderincreaseMV
Respiratorystatus
SaO2 high
PCO2 high
Bloodglucoselevel
LowConsiderincreaseglucoseintake
SafeBoosC
10
B. Urlesberger, Div. Neonatology, Medical University Graz
Next Step: Phase III Multicenter RCT, that may show improved neonatal outcome.
Results - Does it matter ?
B. Urlesberger, Div. Neonatology, Medical University Graz
Conclusion I
8 With NIRS it is possible to measure changes in cerebral oxygenation (and perfusion).
8 It has been shown, that peripheral and cerebral oxygenation show differences in behaviour.
8 Autonomous changes in cerebral blood flow may be associated with that different behaviour.
8 Normal ranges / target ranges are established for cerebral oxygen saturation.
B. Urlesberger, Div. Neonatology, Medical University Graz
Conclusion II - Does it matter ?
8 In two recent Phase II trials it was shown, that interventions based on NIRS were feasible– during resucitation– during first 72h in NICU
8 In the intervention groups it was possible to reduce significantly the primary outcome parameter – burden of cerebral hypoxia.
8 Secondary outcome parameters showed:– Trend to reduce mortality and cerebral injury (SafeBoosC)– Significant reduction in supplemental oxygen (COSGOD)
8 Both trials need Phase III RCT to prove, that neonatal outcome can be improved with such interventions. COSGOD III startet already !
11
B. Urlesberger, Div. Neonatology, Medical University Graz
Conclusion II - Does it matter ?
8 In two recent Phase II trials it was shown, that interventions based on NIRS were feasible.– during resucitation– during first 72h in NICU
8 In the intervention groups it was possible to reduce significantly the primary outcome parameter – burden of cerebral hypoxia.
8 Secondary outcome parameters showed:– Trend to reduce mortality and cerebral injury (SafeBoosC)– Significant reduction in supplemental oxygen (COSGOD)
8 Both trials need Phase III RCT to prove, that neonatal outcome can be improved with such interventions. COSGOD III startet already !
B. Urlesberger, Div. Neonatology, Medical University Graz
Conclusion II - Does it matter ?
8 In two recent Phase II trials it was shown, that interventions based on NIRS were feasible.– during resucitation– during first 72h in NICU
8 In the intervention groups it was possible to reduce significantly the primary outcome parameter – burden of cerebral hypoxia.
8 Secondary outcome parameters showed:– Trend to reduce mortality and cerebral injury (SafeBoosC)– Significant reduction in supplemental oxygen (COSGOD)
8 Both trials need Phase III RCT to prove, that neonatal outcome can be improved with such interventions. COSGOD III startet already !
Medizinische Universität Graz, Universitätsplatz 3, A-8010 Graz, www.medunigraz.at
Thank you for your attention !